Login / Signup

Paid Sick Leave and Risks of All-Cause and Cause-Specific Mortality among Adult Workers in the USA.

Daniel Kim
Published in: International journal of environmental research and public health (2017)
Background: The USA is one of only a few advanced economies globally that does not guarantee its workers paid sick leave. While there are plausible reasons why paid sick leave may be linked to mortality, little is known empirically about this association. Methods: In a pooled USA nationally-representative longitudinal sample of 57,323 working adults aged 18-85 years from the National Health Interview Surveys 2000-2002, paid sick leave was examined as a predictor of all-cause and cause-specific mortality. Multivariate Cox proportional hazards models were used to estimate the impact of paid sick leave on mortality. Results: Having paid sick leave through one's job was associated with 10% (hazards ratio, HR = 0.90; 95% CI = 0.81-0.996; p = 0.04), 14% (HR = 0.86; 95% CI = 0.74-0.99; p = 0.04), and 22% (HR = 0.78; 95% CI = 0.65-0.94; p = 0.01) significantly lower hazards of all-cause mortality after mean follow-up times of 11.1, 6.5, and 4.5 years, respectively. This study further identified associations of paid sick leave with 24% (HR = 0.76; 95% CI = 0.59-0.98; p = 0.03), and 35% (HR = 0.65; 95% CI = 0.44-0.95; p = 0.03) lower hazards of dying from heart diseases and unintentional injuries, respectively. Conclusions: To the author's knowledge, this study provides the first empirical evidence on the linkages between paid sick leave and mortality and supports protective effects, particularly against heart diseases and unintentional injuries. The most salient association corresponded to a lag period of just less than five years. Social policies that mandate paid sick leave may help to reduce health inequities and alleviate the population burden of mortality among working adults in the USA.
Keyphrases
  • cardiovascular events
  • risk factors
  • healthcare
  • public health
  • mental health
  • type diabetes
  • cardiovascular disease
  • atrial fibrillation
  • clinical trial
  • risk assessment
  • social support
  • study protocol